Alligator Bioscience Names CFO Johan Giléus CEO Effective Jan. 1, 2027

PUBT · 2d ago
Alligator Bioscience Names CFO Johan Giléus CEO Effective Jan. 1, 2027
  • Alligator Bioscience appointed CFO Johan Giléus as CEO effective January 1, 2027, succeeding Søren Bregenholt.
  • Giléus will combine the CEO and CFO roles.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alligator Bioscience AB published the original content used to generate this news brief on October 22, 2026, and is solely responsible for the information contained therein.